HS
Himank Shah
About Himank Shah
Data last updated:
Himank Shah is a Director at Trinix Pharma Private Limited (since 2018), Director at Vyonil Pharma Private Limited (since 2022) and Designated Partner at Tnv Lifescience Llp (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Chemicals and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹12.49 Cr; the largest is Trinix Pharma Private Limited at ₹12.49 Cr (FY 2024). Earlier, Himank Shah was a Director at Nest Healthcare Private Limited (2014–2018) and Director at Sharnya Infrabuild Private Limited (2014–2019) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Trinix Pharma Private Limited U24100GJ2018PTC101736 | Director | 10 Apr 2018 | 2018 | ₹12.49 Cr (FY 2024) | Active |
 Vyonil Pharma Private Limited U24290GJ2021PTC123254 | Director | 10 Oct 2022 | 2021 | ₹63,000 (FY 2025) | Active |
| Tnv Lifescience Llp ACA-6305 | Designated Partner | 18 Apr 2023 | 2023 | Active | |
| Gnv Life Science Llp ACA-3389 | Designated Partner | 22 Mar 2023 | 2023 | Active | |
| Zynex Lifescience Llp AAI-7414 | Designated Partner | 03 Mar 2017 | 2017 | Active | |
| Caper Lifescience Llp AAI-0859 | Designated Partner | 22 Dec 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nest Healthcare Private Limited U24232GJ2014PTC079983 | Director | 03 Jul 2014 | 2014 | ₹18.02 Cr (FY 2024) | Active |
| Sharnya Infrabuild Private Limited U45200GJ2014PTC080704 | Director | 04 Sep 2014 | 2014 | Active | |
| Nest Impex Private Limited U51397GJ2011PTC067574 | Director | 21 Oct 2011 | 2011 | Strike Off | |
| Nestro Pharma Private Limited U24230GJ2013PTC076371 | Director | 12 Aug 2013 | 2013 | Strike Off | |
| Rhb Pharma Llp AAF-4488 | Designated Partner | 07 Jan 2016 | 2016 | Active | |
| Abhishree Infrastructure Private Limited U45201GJ2012PTC071459 | Director | 07 Aug 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Himank Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Himank Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Himank Shah
Himank Shah currently holds 6 directorships: Trinix Pharma Private Limited (Director, since 10 Apr 2018, revenue ₹12.49 Cr (FY 2024)); Vyonil Pharma Private Limited (Director, since 10 Oct 2022, revenue ₹63,000 (FY 2025)); Tnv Lifescience Llp (Designated Partner, since 18 Apr 2023); Gnv Life Science Llp (Designated Partner, since 22 Mar 2023); Zynex Lifescience Llp (Designated Partner, since 03 Mar 2017); and 1 more.
Himank Shah was first appointed on 21 Oct 2011 as Director at Nest Impex Private Limited. The most recent appointment on record is 18 Apr 2023 at Tnv Lifescience Llp.
The 2 current companies of Himank Shah that report revenue have a combined latest revenue of ₹12.49 Cr: Trinix Pharma Private Limited ₹12.49 Cr (FY 2024); Vyonil Pharma Private Limited ₹63,000 (FY 2025).
Himank Shah held 6 earlier board appointments: Nest Healthcare Private Limited (Director, 03 Jul 2014 to 08 Mar 2018); Sharnya Infrabuild Private Limited (Director, 04 Sep 2014 to 11 Jul 2019); Nest Impex Private Limited (Director, 21 Oct 2011 to 30 Apr 2019); Nestro Pharma Private Limited (Director, 12 Aug 2013 to 11 Jul 2019); Rhb Pharma Llp (Designated Partner, 07 Jan 2016 to 24 Aug 2018); and 1 more.
The current boards of Himank Shah's companies include Anil Gupta Vishwambhardayal (Trinix Pharma Private Limited), Bhavik Arvindbhai Shah (Trinix Pharma Private Limited), Pradip Srivastava (Trinix Pharma Private Limited), Prashant Srivastava (Trinix Pharma Private Limited), Vimalkumar Anilkumar Gupta (Trinix Pharma Private Limited), Naimesh Jagdishbhai Thakore (Vyonil Pharma Private Limited), among others.